A great privilege to work with Prof. Emens and the rest of the team... Enjoy our new review "Breast Cancer Vaccines: Heeding the Lessons of the Past to Guide a Path Forward" cancertreatmentreviews.com/article/S0305-…

Please, enjoy our latest effort on: "Homologous Recombination Repair Deficiency and the Immune Response in ..." sciencedirect.com/science/articl…

AddThis | Home authors.elsevier.com/a/1aN0d15X3~MU… Free access till end of February 😊

Cinzia Solinas, MD PhD Matteo Lambertini, MD PhD Great paper , well done.

Please, enjoy our latest effort on Radiology and Immuno-Oncology: "Immune Checkpoint Inhibitor-Induced Pancreatic Injury: Imaging Findings and Literature Review pubmed.ncbi.nlm.nih.gov/31925647/" Congrats to all coauthors and...on to the next successess!

The rationale behind targeting the ICOS-ICOS ligand costimulatory pathway in cancer immunotherapy esmoopen.bmj.com/content/5/1/e0…

➡️ #IORESTOACASA ⬅️ Lascia il virus fuori dalla porta. Resta a casa ed esci solo per esigenze essenziali. #coronavirusitalia #covid19 #covid19italia

Just published in #EJCI the results of the first #survey investigating how the management of #immunotherapy to treat #cancer changed during #COVID19. A great effort! 💪🏻 Matteo Lambertini, MD PhD Massimo Di Maio Francesca Poggio Benedetta Conte Lucia Del Mastro #OncoAlert onlinelibrary.wiley.com/doi/abs/10.111…

Finally out in ASCO Publications our #survey assessing the impact of #COVID19 outbreak on attitudes and practice of Italian #oncologists toward #BreastCancer care and related #research activities: great job team! #OncoAlert #UNIGEnonsiferma #bcsm #JCOOP Link: ascopubs.org/doi/full/10.12…

A critical evaluation of glucocorticoids in the management of severe C... sciencedirect.com/science/articl…, the latest effort of a multidisciplinary team (oncologists,diabetes specialist,immunobiologist and infectologist) from ATS Sardegna, Columbia University (NYC) and Spallanzani (Rome)

Great news for our Journal! Thanks for the support of all the authors and editorial board members! OncoAlert

Astonishing! Great achievement. Congrats to FabriceAndre soria, staff and associate editors.

Excellent news after years of rigorous work. Congrats! Proud to be part of the team ESMO Open

Looking forward to discussing with you later today in OncoViews the most important updates in #GynecologicalCancer and #BreastCancer from #ASCO20 #OncoAlert #UNIGEnonsiferma Università di Genova Ospedale San Martino Genova #bcsm #gcsm #OspedalePoliclinicoSanMartino #ospedaleSanMartino

Here you are an overview of PD-L2 in cancer! Programmed Cell Death-Ligand 2: A Neglected But Important Target in th... sciencedirect.com/science/articl…

Enjoy a nice overview of radiomics and cancer immunotherapy, the latest effort of a multidisciplinary team of radiologists, oncologists and immunologists! Radiomics and “radi-…omics” in cancer immunotherapy: a guide for clinicians sciencedirect.com/science/articl…

Marta Perachino @FraParisi_MD Maria Grazia Razeti Maria Maddalena Latocca Marco Tagliamento Claudia Massarotti, MD Cinzia Solinas, MD PhD Matteo Lambertini, MD PhD

Here you are a commentary on ICB and TIL in early stage HER2-pos BC! Immune Checkpoint Blockade in HER2-Positive Breast Cancer: What Role in Early Disease Setting? mdpi.com/1057024 via MDPI

Congratulations🎉Ad maiora...with amazing oncologists

Awesome!